Published in J Histochem Cytochem on April 07, 2014
CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance. Oncotarget (2015) 0.83
The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy. Ann Transl Med (2015) 0.77
Clinical significance of OCT4 and SOX2 protein expression in cervical cancer. BMC Cancer (2015) 0.75
Ino80 promotes cervical cancer tumorigenesis by activating Nanog expression. Oncotarget (2016) 0.75
Sex-determining region of Y chromosome-related high-mobility-group box 2 in malignant tumors: current opinions and anticancer therapy. Chin Med J (Engl) (2015) 0.75
Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget (2017) 0.75
The "virgin birth", polyploidy, and the origin of cancer. Oncoscience (2014) 0.75
Ionizing Particle Radiation as a Modulator of Endogenous Bone Marrow Cell Reprogramming: Implications for Hematological Cancers. Front Oncol (2015) 0.75
Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer. Yonsei Med J (2018) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42
Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature (2009) 10.31
Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem (2005) 6.05
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer (2008) 4.71
Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol (2005) 4.54
Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J Biol Chem (2004) 3.73
Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer (2008) 3.56
Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res (2007) 3.56
SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells (2009) 3.54
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res (2008) 3.32
Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer (2005) 2.84
Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene (2011) 2.73
Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res (2002) 2.49
Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol (2009) 1.89
Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res (2009) 1.87
EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Cancer Res (2009) 1.79
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer (2011) 1.74
OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer (2007) 1.68
Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology (2011) 1.55
Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am J Surg Pathol (2010) 1.53
Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr Mol Med (2009) 1.50
Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. PLoS One (2013) 1.41
Increased expression of pAKT is associated with radiation resistance in cervical cancer. Br J Cancer (2006) 1.28
Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer (2012) 1.27
Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis. Pancreas (2010) 1.27
Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res (2010) 1.27
Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol (2009) 1.23
Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Oncol Rep (2009) 1.20
Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression. Oncogene (2010) 1.19
Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother Oncol (2007) 1.13
A dominant role for p53-dependent cellular senescence in radiosensitization of human prostate cancer cells. Cell Cycle (2007) 1.08
Cell cycle suspension: a novel process lurking in G₂ arrest. Cell Cycle (2011) 1.07
Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86. Br J Cancer (2009) 1.06
Cancer stem cells and radiotherapy. Int J Radiat Biol (2009) 1.06
Discovery of the cancer stem cell related determinants of radioresistance. Radiother Oncol (2013) 1.01
Cancer stem cells: targets and potential biomarkers for radiotherapy. Clin Cancer Res (2011) 0.99
Cancer stem cells as a predictive factor in radiotherapy. Semin Radiat Oncol (2012) 0.95
Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation. Radiother Oncol (2010) 0.90
Studies on the inhibition of feline EGFR in squamous cell carcinoma: enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors. Cancer Biol Ther (2011) 0.86
Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation. Int J Oncol (2010) 0.82
Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models. Clin Cancer Res (2008) 0.81
Over-expression of Sox2 in C3H10T1/2 cells inhibits osteoblast differentiation through Wnt and MAPK signalling pathways. Int Orthop (2011) 0.81
Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy. Gynecol Oncol (2006) 0.80
Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice. Int J Radiat Oncol Biol Phys (2004) 0.76